BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 30127633)

  • 1. Clinical features related to xeroderma pigmentosum in a Brazilian patient diagnosed at advanced age.
    Ribeiro MG; Zunta GL; Santos JS; Moraes AM; Lima CSP; Ortega MM
    Appl Clin Genet; 2018; 11():89-92. PubMed ID: 30127633
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DNA repair processes protect human beings from premature solar skin damage: evidence from studies on xeroderma pigmentosum.
    Robbins JH; Moshell AN
    J Invest Dermatol; 1979 Jul; 73(1):102-7. PubMed ID: 448168
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Postoperative neurological aggravation after anesthesia with sevoflurane in a patient with xeroderma pigmentosum: a case report.
    Fjouji S; Bensghir M; Yafat B; Bouhabba N; Boutayeb E; Azendour H; Kamili ND
    J Med Case Rep; 2013 Mar; 7():73. PubMed ID: 23497518
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Xeroderma pigmentosum: a case report and review of the literature.
    Feller L; Wood NH; Motswaledi MH; Khammissa RA; Meyer M; Lemmer J
    J Prev Med Hyg; 2010 Jun; 51(2):87-91. PubMed ID: 21155411
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Xeroderma pigmentosum neurological abnormalities correlate with colony-forming ability after ultraviolet radiation.
    Andrews AD; Barrett SF; Robbins JH
    Proc Natl Acad Sci U S A; 1978 Apr; 75(4):1984-8. PubMed ID: 273925
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of excision repair in UVB-induced depletion and recovery of human epidermal Langerhans cells.
    Jimbo T; Ichihashi M; Mishima Y; Fujiwara Y
    Arch Dermatol; 1992 Jan; 128(1):61-7. PubMed ID: 1739289
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Germline and somatic mutations of the INK4a-ARF gene in a xeroderma pigmentosum group C patient.
    Soufir N; Ribojad M; Magnaldo T; Thibaudeau O; Delestaing G; Daya-Grosjean L; Rivet J; Sarasin A; Basset-Seguin N
    J Invest Dermatol; 2002 Dec; 119(6):1355-60. PubMed ID: 12485439
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Light protection for xeroderma pigmentosum].
    Ettinger M; Berneburg M
    Hautarzt; 2017 May; 68(5):359-363. PubMed ID: 28401271
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Xeroderma pigmentosum: children of the moon].
    Herouy Y; Krutmann J; Norgauer J; Schöpf E
    J Dtsch Dermatol Ges; 2003 Mar; 1(3):191-8. PubMed ID: 16285494
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Xeroderma Pigmentosum-Associated Childhood Interstitial Lung Disease.
    Kamble S; Utpat K; Desai U; Joshi J; Bharmal R
    Turk Thorac J; 2022 Mar; 23(2):192-195. PubMed ID: 35404252
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Xeroderma pigmentosum.
    Norgauer J; Idzko M; Panther E; Hellstern O; Herouy Y
    Eur J Dermatol; 2003; 13(1):4-9. PubMed ID: 12609773
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel therapeutic approaches to xeroderma pigmentosum.
    Weon JL; Glass DA
    Br J Dermatol; 2019 Aug; 181(2):249-255. PubMed ID: 30265743
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Xeroderma pigmentosum: an updated review.
    Leung AK; Barankin B; Lam JM; Leong KF; Hon KL
    Drugs Context; 2022; 11():. PubMed ID: 35520754
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Xeroderma Pigmentosum - Facts and Perspectives.
    Lehmann J; Seebode C; Martens MC; Emmert S
    Anticancer Res; 2018 Feb; 38(2):1159-1164. PubMed ID: 29374753
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Xeroderma pigmentosum and the role of UV-induced DNA damage in skin cancer.
    van Steeg H; Kraemer KH
    Mol Med Today; 1999 Feb; 5(2):86-94. PubMed ID: 10200950
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Xeroderma Pigmentosum - A case report with oral implications.
    Lopes-Cardoso C; Paes da Silva Ramos Fernandes LM; Ferreira-Rocha J; Teixeira-Soares C; Antônio-Barreto J; Humberto-Damante J
    J Clin Exp Dent; 2012 Oct; 4(4):e248-51. PubMed ID: 24558564
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Xeroderma pigmentosum complementation group F: Report of a case and review of Japanese patients.
    Tofuku Y; Nobeyama Y; Kamide R; Moriwaki S; Nakagawa H
    J Dermatol; 2015 Sep; 42(9):897-9. PubMed ID: 26010807
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impaired ultraviolet-B-induced cytokine induction in xeroderma pigmentosum fibroblasts.
    Suzuki H; Kalair W; Shivji GM; Wang B; Toto P; Amerio P; Kraemer KH; Sauder DN
    J Invest Dermatol; 2001 Nov; 117(5):1151-5. PubMed ID: 11710926
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A case of melanoma in xeroderma pigmentosum.
    Rao TN; Bhagyalaxmi A; Ahmed K; Mohana Rao TS; Venkatachalam K
    Indian J Pathol Microbiol; 2009; 52(4):524-6. PubMed ID: 19805962
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Functional retroviral vector for gene therapy of xeroderma pigmentosum group D patients.
    Carreau M; Quilliet X; Eveno E; Salvetti A; Danos O; Heard JM; Mezzina M; Sarasin A
    Hum Gene Ther; 1995 Oct; 6(10):1307-15. PubMed ID: 8590735
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.